Skip to main content

Atlas Venture — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

115
Companies
$4.2B
Total invested
$68.0M
Avg. check
48
Industries
Biotechnology 15Therapeutics 9Medical 7Pharmaceutical 6Health Care 6Artificial Intelligence (AI) 4+42 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 115
Nvelop Therapeutics
September 2023

Nvelop Therapeutics is a biotechnology company that developes genetic medicines for patients with severe genetic diseases.

Biotechnology · Cambridge$100.0M Seed
Robin
September 2022

Most workplace tools create busywork. Robin eliminates it.

Advertising · BostonVenture - Series Unknown
Ackcio
September 2021

Ackcio builds real-time, reliable, wireless, monitoring solutions for industrial applications.

Communications Infrastructure · Singapore$3.0M Series A
DC Connected
August 2024

DC Connected is a technology company focused on AI‑powered vehicle diagnostics and maintenance tools.

Analytics · Nersingen$2.3M Seed
Versanis Bio
August 2021

Versanis Bio discovers and develops medicines that address medical conditions prevalent in older adults.

Biotechnology · Oakland$70.0M Series A
Renasant Bio
July 2025

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Biotechnology · Berkeley$54.5M Seed
K36 Therapeutics
June 2023

K36 Therapeutics translate epigenetic modulation of oncogenic pathways into small molecule therapies.

Biotechnology · Cambridge$70.0M Series B
Ikena Oncology
May 2023

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Biotechnology · Boston$40.0M Post-IPO Equity
Sionna Therapeutics
March 2024

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Biotechnology · Natick$182.0M Series C
Vima Therapeutics
March 2026

Vima Therapeutics operates as a biotechnology company.

Biotechnology · Cambridge$40.0M Series A
Potato Play
February 2022

Potato Play is a Singapore-based publisher turning mobile games from Asia into worldwide hits.

Casual Games · Singapore$5.0M Seed
Arkuda Therapeutics
February 2022

Arkuda Therapeutics is a pharmaceutical company.

Biotechnology · Cambridge$64.0M Series B
Kailera Therapeutics
October 2025

Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

Biotechnology · Waltham$600.0M Series B
Trace Neuroscience
November 2024

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

Biotechnology · South San Francisco$101.0M Series A
Pheon Therapeutics
May 2024

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

Biotechnology · London$120.0M Series B
Accent Therapeutics
January 2024

Accent Therapeutics is a biopharmaceutical company.

Biotechnology · Lexington$75.0M Series C
Comanche Biopharma
January 2024

Our purpose is to make every pregnancy around the world safer.

Biopharma · Concord$75.0M Series B
Priam Cyber
October 2023

AI-Powered Solutions for Scalable, Efficient, and Cost-Effective Cyber Security Operations

Artificial Intelligence (AI) · London$2.4M Seed
Mariana Oncology
September 2023

Mariana Oncology is a biotechnology research industry.

Bioinformatics · Watertown$175.0M Series B
Right-Hand Cybersecurity
March 2023

Right-Hand Cybersecurity is a human risk management platform.

Artificial Intelligence (AI) · Lewes$5.0M Series A
EDITED
March 2023

Edited provides AI-powered retail intelligence software for fashion brands and retailers.

Analytics · London$15.0M Venture - Series Unknown
Bluespec
February 2023

Bluespec develops electronic design synthesis tool sets for integrated circuits and field programmable gate arrays.

Electronic Design Automation (EDA) · Framingham$5.0M Venture - Series Unknown
Remix Therapeutics
January 2024

Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.

Biotechnology · Cambridge$60.0M Venture - Series Unknown
Appcues
January 2022

Appcues provides a no-code platform helping teams to track and analyze product usage and publish in-app tours, announcements, and surveys.

Analytics · Boston$7.0M Debt Financing

Where Atlas Venture invests

Biotechnology15
Therapeutics9
Medical7
Pharmaceutical6
Health Care6
Artificial Intelligence (AI)4

About Atlas Venture's portfolio

How many companies has Atlas Venture invested in?

Atlas Venture has invested in 115 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Atlas Venture invest in?

Atlas Venture's top investment sectors include Biotechnology, Therapeutics, Medical, Pharmaceutical, Health Care. The firm invests across 48 different industry categories.

What is Atlas Venture's largest investment?

Among tracked funding rounds, Kailera Therapeutics received $600.0M in a Series B round. Atlas Venture's total known invested capital is $4.2B.

What is the average investment size for Atlas Venture?

Atlas Venture's average investment size is $68.0M across its portfolio of 115 companies.

What are Atlas Venture's most recent investments?

Recent Atlas Venture portfolio additions include Nvelop Therapeutics, Robin, Ackcio, DC Connected, Versanis Bio. These companies were founded in 2020 or later.

Reach the founders behind these 115 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →